Home
About Us
Research Cores
Publications
News
Contact Us
Careers
BY AUTHOR
Ambrose PG
Bhavnani SM
Forrest A
Hammel JP
Okusanya OO
Rubino CM
Van Wart SA
Rubino CM, Bhavnani SM, Ambrose PG, Forrest A, Loutit JS.
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults. Pulm Pharmacol Ther 2009 Aug; 22(4):279-85.
Ambrose PG, Meagher AK, Passarell JA, Van Wart SA, Cirincione BB, Rubino CM, Korth-Bradley JM, Babinchak T, Ellis-Grosse EJ.
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints. Diagn Microbiol Infect Dis 2009 Feb; 63(2):155-9.
Bhavnani SM, Forrest A, Hammel JP, Drusano GL, Rubino CM, Ambrose PG.
Pharmacokinetics-pharmacodynamics of quinolones against
Streptococcus pneumoniae
in patients with community-acquired pneumonia. Diagn Microbiol Infect Dis 2008 Sep; 62(1):99-101.
Ambrose PG, Forrest A, Craig WA, Rubino CM, Bhavnani SM, Drusano GL, Heine HS.
Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine
Bacillus anthracis
inhalation infection model. Antimicrob Agents Chemother. 2007 Dec;51(12):4351-5. Epub 2007 Sep 17.
Rubino CM, Ma L, Bhavnani SM, Korth-Bradley J, Speth J, Ellis-Grosse E, Rodvold KR, Ambrose PG, Drusano GL.
Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation. Antimicrob Agents Chemother. 2007 Nov;51(11):4085-9. Epub 2007 Sep 10.
Maier G, Rubino C, Hsu R, Grasela T, Baumgartner RA.
Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma. Pulm Pharmacol Ther. 2007;20(5):534-42. Epub 2006 May 27.
Rubino CM, Ambrose P, Cirincione B, Arguedas A, Sher L, Lopez E, Sáez-Llorens X, Grasela DM.
Pharmacokinetics and pharmacodynamics of gatifloxacin in children with recurrent otitis media: application of sparse sampling in clinical development. Diagn Microbiol Infect Dis. 2007 Sep;59(1):67-74.
Rubino CM, Bradley JS.
Optimizing therapy with antibacterial agents: use of pharmacokinetic-pharmacodynamic principles in pediatrics. Paediatr Drugs. 2007;9(6):361-9.
Rubino CM, Capparelli EV, Bradley JS, Blumer JL, Kearns GL, Reed M, Jacobs RF, Cirincione B, Grasela DM.
Population pharmacokinetic model for gatifloxacin in pediatric patients. Antimicrob Agents Chemother. 2007 Apr;51(4):1246-52. Epub 2007 Jan 12.
Ambrose PG, Bhavnani SM, Rubino CM, Louie A, Gumbo T, Forrest A, Drusano GL.
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore. 2007 Jan 1;44(1):79-86.
Jones RN, Rubino CM, Bhavnani SM, Ambrose PG.
Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against
Streptococcus pneumoniae
. Antimicrob Agents Chemother. 2003 Jan;47(1):292-6.
Glover ML, Shaffer CL, Rubino CM, Cuthrell C, Schoening S, Cole E, Potter D, Ransom JL, Gal P.
A multicenter evaluation of gentamicin therapy in the neonatal intensive care unit. Pharmacotherapy. 2001 Jan;21(1):7-10.
Bozovich M, Rubino CM, Edmunds J.
Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy. 2000 Nov;20(11):1375-83. Review.
